Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / S&P BIOTECH
-
Number of holders
-
684
-
Total 13F shares, excl. options
-
84,808,968
-
Shares change
-
+7,625,588
-
Total reported value, excl. options
-
$6,299,641,637
-
Value change
-
+$499,722,376
-
Put/Call ratio
-
98%
-
Number of buys
-
356
-
Number of sells
-
-291
-
Price
-
$74.27
Significant Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q2 2022
892 filings reported holding XBI - SPDR SERIES TRUST - S&P BIOTECH as of Q2 2022.
SPDR SERIES TRUST - S&P BIOTECH (XBI) has 684 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 84,808,968 shares
.
Largest 10 shareholders include MORGAN STANLEY (9,452,090 shares), BANK OF AMERICA CORP /DE/ (9,324,582 shares), GOLDMAN SACHS GROUP INC (6,597,899 shares), CITIGROUP INC (5,050,497 shares), UBS Group AG (4,061,188 shares), BNP PARIBAS ARBITRAGE, SA (3,775,795 shares), TORONTO DOMINION BANK (3,093,885 shares), Clal Insurance Enterprises Holdings Ltd (2,442,000 shares), Avidity Partners Management LP (1,875,000 shares), and Harel Insurance Investments & Financial Services Ltd. (1,200,274 shares).
This table shows the top 684 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.